文献速递湿疹皮炎与荨麻疹

成人特应性湿疹:疾病负担与个体痛苦——一项大型欧盟研究

Atopic eczema: burden of disease and individual suffering - results from a large EU study in adults.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2019-06-06

该研究在9个欧洲国家招募1189例18-87岁中重度特应性湿疹成人患者,通过电话访谈评估疾病严重度与生活质量。尽管接受治疗,45%患者POEM仍为中重度至极重度,57%因皮肤病误工至少1天,55%DLQI中度至极重度受损,10%HADS-D提示抑郁症状,57%存在情绪负担。

要点

  • 中重度成人特应性湿疹患者疾病负担远超可接受水平。
  • 45%患者尽管治疗中POEM仍为中重度至极重度。
  • 57%因皮肤病误工,55%生活质量中度至极重度受损。

核心结论

  • 真实世界研究显示中重度成人特应性湿疹患者承受的痛苦超出可接受范围。
  • 需提高医疗专业人员、政策制定者与公众对该问题的认识。

研究设计与样本

  • 在9个欧洲国家由皮肤科或过敏科医生联合患者组织招募1189例18-87岁中重度特应性湿疹成人患者,56%为女性。
  • 2017年10月至2018年3月由经验丰富访谈员进行计算机辅助电话访谈,使用POEM、DLQI、HADS-D及新开发的AESEC评估。

主要发现

  • 尽管接受当前治疗,45%参与者POEM仍显示中重度至极重度特应性湿疹。
  • 57%因皮肤病在前一年至少误工1天。
  • DLQI显示55%存在中度至极重度受损。
  • HADS-D显示10%得分达到或超过8分阈值,提示抑郁症状。
  • AESEC显示57%存在情绪负担,如试图隐藏湿疹、对湿疹感到内疚、亲密关系问题等。

关键数值与推荐

  • POEM评估显示45%患者为中重度至极重度。
  • DLQI评估显示55%患者为中度至极重度受损。
  • HADS-D以8分为阈值,10%患者达到或超过该阈值提示抑郁症状。
  • AESEC评估显示57%患者存在情绪负担。

临床怎么用

  • 临床应关注中重度成人特应性湿疹患者的生活质量、情绪负担与误工情况。
  • 需提高对特应性湿疹个体痛苦的认识并推动更有效治疗的可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atopic eczema (AE, atopic dermatitis) is one of the most common non-communicable inflammatory skin diseases affecting 1-5% of the adult population in Europe with marked impairment in quality of life. In spite of great progress in understanding the pathophysiology of disturbed skin barrier and immune deviation, AE still represents a problem in daily clinical practice. Furthermore, the true impact of AE on individual suffering is often not recognized. OBJECTIVES: With a large European study, we wanted to provide insights into the actual suffering and individual burden of disease in adult patients with AE. METHODS: A total of 1189 adult patients (18-87 years, 56% female) with moderate to severe AE were recruited in nine European countries by dermatologists or allergists together with the help of patient organizations. A computer-assisted telephone interview was performed by experienced interviewers between October 2017 and March 2018. The following instruments were used to assess severity or measure quality of life: Patient-Oriented Eczema Measure (POEM), Dermatology Life Quality Index (DLQI), Hospital Anxiety and Depression Scale (HADS-D) and a newly developed Atopic Eczema Score of Emotional Consequences (AESEC). Patients were also asked to self-assess the severity of their disease. RESULTS: Despite current treatment, 45% of participants still had actual moderate to very severe AE in POEM. Due to their skin disease, 57% missed at least 1 day of work in the preceding year. DLQI showed moderate to extremely large impairment in 55%. According to HADS-D, 10% scored on or above the threshold of eight points with signs of depressive symptoms. Assessed with AESEC, 57% were emotionally burdened with feelings such as 'trying to hide the eczema', 'feeling guilty about eczema', having 'problems with intimacy' and more. Of persons actually suffering from severe AE, 88% stated that their AE at least partly compromised their ability to face life. CONCLUSIONS: This real-life study shows that adults with a moderate to severe form of AE are suffering more than what would be deemed acceptable. There is a need for increased awareness of this problem among healthcare professionals, policymakers and the general public to support research in the development of new and more effective treatments and provide access to better and affordable health care for affected patients.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Ring J, Zink A, Arents BWM, et al. Atopic eczema: burden of disease and individual suffering - results from a large EU study in adults. J Eur Acad Dermatol Venereol. 2019. PMID: 31002197. doi:10.1111/jdv.15634

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。